Physical Activity Level in Patients with Chronic Kidney Disease During COVID-19 Pandemic

Completed

• Conditions: Covid19; Chronic Kidney Diseases

• Registration Number: NCT04745923
• Lead Sponsor: Hacettepe University

Brief Summary

In the literature, there are no studies evaluating fear of COVID-19, anxiety, depression, physical activity, fear of movement and quality of life in patients with chronic kidney disease during COVID-19 pandemic. The investigators will evaluate these parameters in patients with chronic kidney disease and compare the findings of healthy individuals during COVID-19 pandemic

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Status Verified: 2021-01
• Study Start: 2021-01-20
• Study First Submitted: 2021-02-06
• Study First Submitted QC: 2021-02-06
• Study First Posted: 2021-02-09
• Primary Completion: 2021-02-28
• Study Completion: 2022-09-30
• Last Update Submitted: 2024-11-05
• Last Update Posted: 2024-11-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 190

Inclusion Criteria

• Having been diagnosed with chronic kidney disease
• Being clinically stable
• Volunteering to participate in the research

Read More

Exclusion Criteria

• Having a cognitive problem
• Not being literate

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fear of COVID-19	5 minutes	COVID-19 phobia will be evaluated using Fear of COVID-19 Scale.
Physical activity	5 minutes	Physical activity level will be evaluated using International Physical Activity Questionnaire - Short Form (IPAQ-SF).

Secondary Outcome Measures

Name	Time	Method
Qol	10 minutes	Quality of life will be evaluated using SF-36
Anxiety and depression	5 minutes	Anxiety and depression will be evaluated using Hospital Anxiety and Depression scale (HADS).
Fear of movement	10 minutes	Fear of movement will be evaluated using the Tampa Scale for Kinesiophobia

Trial Locations

Locations (1)

Hacettepe University, Faculty of Physical Therapy and Rehabilitation; 🇹🇷 Ankara, Turkey